Instructive lessons from the analysis of assistance in diabetes during the first phase of COVID-19 pandemic - Acta Diabetologica
Source : https://link.springer.com/article/10.1007/s00592-022-01855-6
Planning specific and periodical controls in diabetes is a common activity in most countries. Early diagnosis, treatment and follow-up of the disease is a principle of preventive medicine supported by...
Relevance: Planning specific and periodical controls in diabetes is a common activity in most countries. Early diagnosis, treatment and follow-up of the disease is a principle of preventive medicine supported by the totality of guidelines. Some previous studies have reported that not undergoing health check-ups was associated with worse...
Using electronic medical record data to assess chronic kidney disease, type 2 diabetes and cardiovascular disease testing, recognition and management as documented in Australian general practice: a cross-sectional analysis - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/35177470/
Using GP EMR data, this study identified recorded diagnoses of chronic vascular diseases generally similar to, or higher than, reported national prevalence. It suggested low levels of extractable documented risk...
Conclusions: Using GP EMR data, this study identified recorded diagnoses of chronic vascular diseases generally similar to, or higher than, reported national prevalence. It suggested low levels of extractable documented risk factor assessments, diagnostic testing in those at risk and prescription of guideline-recommended pharmacotherapy for...
Semaglutide once a week in adults with overweight or obesity, with or without type 2 diabetes in an east Asian population (STEP 6): a randomised, double-blind, double-dummy, placebo-controlled, phase 3a trial
Source : https://www.thelancet.com/journals/landia/article/PIIS2213-8587(22)00008-0/fulltext
Adults from east Asia with obesity, with or without type 2 diabetes, given semaglutide 2·4 mg once a week had superior and clinically meaningful reductions in bodyweight, and greater reductions...
Relevance: Adults from east Asia with obesity, with or without type 2 diabetes, given semaglutide 2·4 mg once a week had superior and clinically meaningful reductions in bodyweight, and greater reductions in abdominal visceral fat area compared with placebo, representing a promising treatment option for weight management in this population.
-
Type 2 Diabetes Connect3yrKey Points • Source: The Lancet Diabetes & Endocrinology • Interpretation: “Adults from east Asia with obesity, with or without type 2 diabetes, given semaglutide 2.4 mg once a week had superior and clinically Show More
Diabetes: Risk Factor and Translational Therapeutic Implications for Alzheimer's Disease
Source : https://onlinelibrary.wiley.com/doi/10.1111/ejn.15619
Jeffrey Cummings , Andrew Ortiz , Janelle Castellino , Jefferson Kinney , Jefferson Kinney Chambers-Grundy Center for Transformative Neuroscience, Department of Brain Health, School of Integrated Health Sciences, University of...
Conclusions: GDF15 and semaglutide reduce food intake and body weight through largely distinct processes that produce greater weight loss and feeding suppression when combined. This article is protected by copyright.
GDF15 and semaglutide inhibit food intake and body weight through largely distinct, additive mechanisms - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/35129264/
doi: 10.1111/dom.14663. Online ahead of print. 1 Institute of Diabetes, Obesity and Metabolism and School of Arts and Sciences, University of Pennsylvania, Philadelphia, PA, USA. 2 Department of Neuroscience, University...
Conclusions: GDF15 and semaglutide reduce food intake and body weight through largely distinct processes that produce greater weight loss and feeding suppression when combined. This article is protected by copyright. All rights reserved.